Medical Research

Grail, a company that aims to use a blood test to spot cancer, has announced a massive round of funding for its experimental approach. A billion dollars sounds like a lot of money. But when your ambitions are as big as the...

One of the best parts of this job, being a news gatherer and news distributor for all of you is getting to know about several great companies and the dedicated people who make them go. One of those companies is Indica Labs based in New...

  In 2010, results of a phase 3 randomized controlled trial showed that targeted therapy directed against HER2 statistically significantly prolonged overall survival compared with chemotherapy alone in patients with HER2–positive...

Indica Labs would like to formally invite you to our West Coast Quantitative Pathology and User Meeting which will be held on Wednesday January 25th, 2017 at the Bentley Reserves in San Francisco, California from 1 - 5 PM. Customer presenters...

This kind of news seems to come up with some regular frequency - "To screen or not to screen, that is the question". This Danish study recently reported in the Annals of Internal Medicine found that screening was not associated with a lower...

OptraSCAN On-Demand Digital Pathology to Provide Robust Multiparametric Whole Slide Imaging System to the NINDS for Brain Injury Studies OptraSCAN has been chosen by the National Institute of Neurological Disorders and Stroke (NINDS), NIH to...